ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
CytoReason and Pfizer Extend Collaboration to Leverage Machine Learning in Drug Development
February 15, 2022CytoReason announced the extension of its collaboration agreement with Pfizer. -
CytoReason Collaborates with Sanofi, Using its AI Technology to Gain Better Understanding of Disease Mechanisms
June 18, 2021CytoReason today announced the initiation of a project with French global biopharmaceutical company Sanofi, which will utilize its cell-centered models and deconvolution techniques to suggest mechanistic insights for each asthma endotype. -
Pfizer partners with CytoReason on immune system models for drug discovery
January 09, 2019Israeli-machine learning company CytoReason has announced it has signed a collaboration agreement with Pfizer in which the latter will leverage the former’s technology to create cell-based models of the immune system..... -
CytoReason uses artificial intelligence to personalise drug treatments
March 26, 2018Cytoreason uncovers a unique biomarker that can predict who will respond and who will not to anti TNF drugs helping thousands of patients gain proper treatment
Pharma Sources Insight January 2025
